Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by N. Khanafer
Ineffective Anti PD-1 Therapy After BRAF Inhibitor Failure in Advanced Melanoma
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
Factors Influencing the Efficacy of Anti-Pd-1 Therapy in Chinese Patients With Advanced Melanoma
Journal of Oncology
Oncology
Oral Lichen Planus Developing After PD-1 Inhibitor Therapy in Two Patients With Malignant Melanoma
Journal of Clinical and Investigative Dermatology
Cessation of Targeted Therapy After a Complete Response in BRAF-mutant Advanced Melanoma: A Case Series
British Journal of Cancer
Cancer Research
Oncology
SCLE and Dermatomyositis in Anti‐PD‐1 Therapy
British Journal of Dermatology
Dermatology
Medicine
Comment on ‘Efficacy and Toxicity of Treatment With the Anti-Ctla-4 Antibody Ipilimumab in Patients With Metastatic Melanoma After Prior Anti-Pd-1 Therapy’
British Journal of Cancer
Cancer Research
Oncology
TNFα Blockade Overcomes Resistance to Anti-Pd-1 in Experimental Melanoma
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Safety and Tumor Responses With Lambrolizumab (Anti–PD-1) in Melanoma
New England Journal of Medicine
Medicine
Systemic Therapy for Previously Untreated Advanced BRAF-mutated Melanoma: Navigating a Shifting Landscape
Immunotherapy
Oncology
Allergy
Immunology
2241. Outcomes of Program Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1(pd-L1) Inhibitor Therapy in HIV Patients With Advanced Cancer
Open Forum Infectious Diseases
Oncology
Neurology
